ORIC icon

Oric Pharmaceuticals
ORIC

Overview Fund Activity

90 hedge funds and large institutions have $291M invested in Oric Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.

Holders
90
Holders Change
+7
Holders Change %
+8.43%
% of All Funds
1.44%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
16
Increased
27
Reduced
28
Closed
9
Calls
$216K
Puts
$285K
Net Calls
-$69K
Net Calls Change
+$630K

Top Buyers

1
BlackRock
1
BlackRock
New York
$22.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.7M
3
VC
3
Vivo Capital
California
$4.71M
4
Franklin Resources
4
Franklin Resources
California
$4.54M
5
Alkeon Capital Management
5
Alkeon Capital Management
New York
$21M

Top Sellers

1
SCM
1
Suvretta Capital Management
New York
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$18.9M
3
SCM
3
Silverarc Capital Management
Massachusetts
$6.8M
4
O
4
OrbiMed
New York
$5.41M
5
PM
5
Prosight Management
Texas
$15.6M
Name Market Value Shares Shares
Change 		Shares
Change %
NS
101
NBC Securities
Alabama
$0 118 +118 New
1 2 3 4
5